Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
An Autologous NK/CIK Cell Product (PB101) in Combination With EGFR-TKI for Treating Lung Cancer
ClinicalTrials.gov study NCT07271446. IPD Sharing: NO. Countries: 1. Publications: 30.
A Dose-Escalation Study of RO5083945 in Patients With Metastatic and/or Locally Advanced Malignant Epidermal Growth Factor Receptor (EGFR)+ Solid Tumors.
ClinicalTrials.gov study NCT00721266. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Role of Circulating Tumour DNA Testing in Assessing for Alterations of Primary Anti-EGFR Resistance in RAS/RAF Wild-type Metastatic Colorectal Cancer Patients
ClinicalTrials.gov study NCT05051592. IPD Sharing: NO. Countries: 1. Publications: 8.
Icotinib Versus First-line Chemotherapy Plus Maintenance Treatment in EGFR Positive Lung Adenocarcinoma Patients
ClinicalTrials.gov study NCT01719536. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Clinical Study of the Combination of Anlotinib and Aumolertinib in the First-line Treatment of Advanced NSCLC With EGFR 21L858R Mutation
ClinicalTrials.gov study NCT06102928. IPD Sharing: NO. Countries: 1. Publications: 8.
Osimertinib in First and Second Line Treatment of NSCLC Harboring EGFR Mutations From Circulating Tumor DNA
ClinicalTrials.gov study NCT02769286. IPD Sharing: NO. Countries: 1. Publications: 3.
A Study Evaluating the Safety, Pharmacokinetics, and Anti-tumor Activity of ABBV-321 in Subjects With Advanced Solid Tumors Associated With Overexpression of the Epidermal Growth Factor Receptor (EGFR
ClinicalTrials.gov study NCT03234712. IPD Sharing: NO. Countries: 3. Publications: 1.
Treatment Patterns, Outcomes and Testing in EGFRm NSCLC Patients With EGFR TKI 1L Across Europe (REFLECT)
ClinicalTrials.gov study NCT04031898. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Correlation Between Efficacy of Osimertinib and EGFR T790M Status and Ratio Via ddPCR in NSCLC
ClinicalTrials.gov study NCT05458726. IPD Sharing: NO. Countries: 1. Publications: 1.
Icotinib or Whole Brain Irradiation in EGFR-mutant Lung Cancer
ClinicalTrials.gov study NCT01724801. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLC
ClinicalTrials.gov study NCT04636593. IPD Sharing: NO. Countries: 1. Publications: 1.
An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors
ClinicalTrials.gov study NCT04305795. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer with Leptomeningeal Disease
ClinicalTrials.gov study NCT05257967. IPD Sharing: NO. Countries: 1. Publications: 2.
The Molecular Mechanism of RAS Wild-type mCRC Resistance to Anti-EGFR-antibody
ClinicalTrials.gov study NCT04466267. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Atezolizumab in Combination With Bevacizumab, Carboplatin and Pemetrexed for EGFR-mutant Metastatic NSCLC Patients After Failure of EGFR Tyrosine Kinase Inhibitors
ClinicalTrials.gov study NCT03647956. IPD Sharing: UNDECIDED. Countries: 1. Publications: 21.
Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC
ClinicalTrials.gov study NCT03711422. IPD Sharing: NO. Countries: 1. Publications: 2.
Evaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Cancer After Failure of Platinum and Cetuximab or Anti-EGFR-based Therapy and Harboring an Homozygous D
ClinicalTrials.gov study NCT03356223. IPD Sharing: Not stated. Countries: 1. Publications: 14.
Preoperative Gefitinib for EGFR Mutant II-IIIa NSCLC (ECTOP-1001)
ClinicalTrials.gov study NCT01833572. IPD Sharing: Not stated. Countries: 1. Publications: 11.
Lazertinib in Patients With NSCLC With Asymptomatic or Mild Symptomatic Brain Metastases After Failure of EGFR TKI.
ClinicalTrials.gov study NCT05326425. IPD Sharing: NO. Countries: 1. Publications: 4.
Afatinib in Previously Treated ESCC With EGFR Overexpression or EGFR Amplification (ESCC-A01)
ClinicalTrials.gov study NCT03940976. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.